Related Experiment Video
Updated: May 10, 2025
00:04
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
The Representative Studies Rubric: A Tool for Diversity in Clinical Trials
Brian Minalga1, Rona Siskind2, Russell Campbell1
1The Legacy Project, Office of HIV/AIDS Network Coordination, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
AJOB Empirical Bioethics
|April 28, 2025
Summary
A new tool, the Representative Studies Rubric (RSR), assesses clinical trial diversity. It helps ensure studies include varied populations, addressing health disparities and improving research validity.
Area of Science:
- Clinical Trials and Health Equity
- Public Health Research Methodologies
- Biomedical Research Ethics
Background:
- Clinical trial underrepresentation compromises generalizability, safety, and efficacy.
- Health disparities are exacerbated when diverse populations are excluded from research.
- Lack of diversity in trials erodes public trust in science and medicine.
Purpose of the Study:
- To introduce the Representative Studies Rubric (RSR) for evaluating clinical trial diversity.
- To assess the enrollment practices of NIH-funded HIV/AIDS Clinical Trials Networks.
- To identify research patterns limiting participation of underrepresented groups.
Main Methods:
- Development of the Representative Studies Rubric (RSR) questionnaire.
- Analysis of active studies within NIH-funded HIV/AIDS Clinical Trials Networks.
- Evaluation of trial designs focusing on age, ethnicity, gender, race, and other demographics.
Main Results:
- Identified research practices that may hinder the enrollment of diverse populations.
- Highlighted ethical implications of exclusionary research in HIV/AIDS studies.
- Demonstrated the utility of the RSR in uncovering participation barriers.
Conclusions:
- The Representative Studies Rubric (RSR) is a valuable tool for promoting inclusive clinical trials.
- Formal adoption of the RSR by HIV/AIDS Networks aims to correct exclusionary practices.
- Standardizing the RSR promotes more representative study populations and equitable health outcomes.
Related Concept Videos
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
01:12Hazard Ratio
64
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
64
01:13Randomized Experiments
6.6K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.6K
01:12Statistical Software for Data Analysis and Clinical Trials
308
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
308
01:11Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K